Madan, Esha
Parker, Taylor M.
Bauer, Matthias R.
Dhiman, Alisha
Pelham, Christopher J.
Nagane, Masaki
Kuppusamy, M. Lakshmi
Holmes, Matti
Holmes, Thomas R.
Shaik, Kranti
Shee, Kevin
Kiparoidze, Salome
Smith, Sean D.
Park, Yu-Soon A.
Gomm, Jennifer J.
Jones, Louise J.
Tomás, Ana R.
Cunha, Ana C.
Selvendiran, Karuppaiyah
Hansen, Laura A.
Fersht, Alan R.
Hideg, Kálmán
Gogna, Rajan
Kuppusamy, Periannan
Funding for this research was provided by:
Krebsliga Schweiz (Swiss Cancer League) (Cancer research grant)
University of Arkansas for Medical Sciences (UAMS) (Seeds of Science)
Creighton University (CU) (Startup funds)
Országos Tudományos Kutatási Alapprogramok (OTKA) (Research Grant)
This article is maintained by: Elsevier
Article Title: The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53
Journal Title: Journal of Biological Chemistry
CrossRef DOI link to publisher maintained version: https://doi.org/10.1074/jbc.RA117.000950
Content Type: article
Copyright: © 2018 by The American Society for Biochemistry and Molecular Biology, Inc.